UnitedHealth Group Incorporated (UNH) Stake Lessened by Rothschild Asset Management Inc.
Rothschild Asset Management Inc. trimmed its position in UnitedHealth Group Incorporated (NYSE:UNH) by 14.3% during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 436,704 shares of the healthcare conglomerate’s stock after selling 72,756 shares during the quarter. UnitedHealth Group makes up approximately 0.9% of Rothschild Asset Management Inc.’s portfolio, making the stock its 13th biggest holding. Rothschild Asset Management Inc.’s holdings in UnitedHealth Group were worth $80,973,000 at the end of the most recent reporting period.
Other institutional investors have also recently made changes to their positions in the company. Honeywell International Inc. purchased a new stake in shares of UnitedHealth Group in the first quarter worth about $35,262,000. Suntrust Banks Inc. lifted its holdings in shares of UnitedHealth Group by 8.5% in the first quarter. Suntrust Banks Inc. now owns 260,811 shares of the healthcare conglomerate’s stock worth $42,774,000 after buying an additional 20,541 shares in the last quarter. Moody Lynn & Lieberson LLC lifted its holdings in shares of UnitedHealth Group by 569.9% in the second quarter. Moody Lynn & Lieberson LLC now owns 8,937 shares of the healthcare conglomerate’s stock worth $1,657,000 after buying an additional 7,603 shares in the last quarter. Shell Asset Management Co. lifted its holdings in shares of UnitedHealth Group by 0.8% in the second quarter. Shell Asset Management Co. now owns 157,241 shares of the healthcare conglomerate’s stock worth $29,156,000 after buying an additional 1,254 shares in the last quarter. Finally, Blair William & Co. IL lifted its holdings in shares of UnitedHealth Group by 34.5% in the first quarter. Blair William & Co. IL now owns 107,415 shares of the healthcare conglomerate’s stock worth $17,648,000 after buying an additional 27,560 shares in the last quarter. 86.19% of the stock is currently owned by hedge funds and other institutional investors.
UnitedHealth Group Incorporated (NYSE UNH) opened at 195.75 on Thursday. The company has a market cap of $189.26 billion, a PE ratio of 23.52 and a beta of 0.63. The stock has a 50 day moving average of $195.56 and a 200 day moving average of $181.26. UnitedHealth Group Incorporated has a one year low of $133.03 and a one year high of $200.76.
UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Tuesday, July 18th. The healthcare conglomerate reported $2.46 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $2.38 by $0.08. UnitedHealth Group had a return on equity of 21.52% and a net margin of 4.32%. The company had revenue of $50.05 billion for the quarter, compared to analyst estimates of $49.97 billion. During the same quarter in the prior year, the firm posted $1.96 EPS. UnitedHealth Group’s quarterly revenue was up 7.7% compared to the same quarter last year. On average, analysts anticipate that UnitedHealth Group Incorporated will post $9.87 earnings per share for the current fiscal year.
The business also recently declared a quarterly dividend, which was paid on Tuesday, September 19th. Investors of record on Friday, September 8th were issued a dividend of $0.75 per share. The ex-dividend date of this dividend was Thursday, September 7th. This represents a $3.00 annualized dividend and a yield of 1.53%. UnitedHealth Group’s payout ratio is presently 35.13%.
A number of brokerages have recently issued reports on UNH. Cantor Fitzgerald reissued a “buy” rating and issued a $205.00 price target on shares of UnitedHealth Group in a report on Friday, July 7th. Sanford C. Bernstein reaffirmed an “outperform” rating and issued a $190.00 target price on shares of UnitedHealth Group in a research note on Monday, July 10th. Credit Suisse Group reaffirmed an “outperform” rating and issued a $200.00 target price (up from $195.00) on shares of UnitedHealth Group in a research note on Thursday, July 13th. Citigroup Inc. raised their target price on shares of UnitedHealth Group from $195.00 to $213.00 and gave the company a “buy” rating in a research note on Wednesday, July 19th. Finally, Royal Bank Of Canada reaffirmed a “buy” rating and issued a $212.00 target price on shares of UnitedHealth Group in a research note on Thursday, July 20th. One investment analyst has rated the stock with a hold rating and twenty-five have issued a buy rating to the stock. UnitedHealth Group presently has a consensus rating of “Buy” and a consensus target price of $203.41.
COPYRIGHT VIOLATION WARNING: This story was first published by Daily Political and is the sole property of of Daily Political. If you are viewing this story on another domain, it was illegally stolen and reposted in violation of U.S. & international trademark & copyright laws. The original version of this story can be viewed at https://www.dailypolitical.com/2017/09/21/unitedhealth-group-incorporated-unh-stake-lessened-by-rothschild-asset-management-inc.html.
In related news, Director Gail R. Wilensky sold 5,600 shares of the stock in a transaction on Tuesday, September 5th. The stock was sold at an average price of $199.49, for a total transaction of $1,117,144.00. Following the sale, the director now owns 60,834 shares in the company, valued at approximately $12,135,774.66. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director William C. Ballard, Jr. sold 5,000 shares of the stock in a transaction on Thursday, August 3rd. The shares were sold at an average price of $193.98, for a total value of $969,900.00. Following the sale, the director now owns 76,058 shares in the company, valued at approximately $14,753,730.84. The disclosure for this sale can be found here. Insiders have sold a total of 76,174 shares of company stock worth $14,981,909 in the last 90 days. 0.89% of the stock is currently owned by insiders.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Receive News & Ratings for UnitedHealth Group Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Incorporated and related companies with MarketBeat.com's FREE daily email newsletter.